RNA-Based Antipsoriatic Gene Therapy: An Updated Review Focusing on Evidence from Animal Models
DOI: https://doi.org/10.2147/dddt.s447780
IF: 4.3188
2024-04-23
Drug Design Development and Therapy
Abstract:Zih-Chan Lin, 1 Chi-Feng Hung, 2– 4 Ibrahim A Aljuffali, 5 Ming-Hsien Lin, 6 Jia-You Fang 7– 9 1 Chronic Diseases and Health Promotion Research Center, Chang Gung University of Science and Technology, Puzi, Chiayi, Taiwan; 2 School of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan; 3 Program in Pharmaceutical Biotechnology, Fu Jen Catholic University, New Taipei City, Taiwan; 4 School of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan; 5 Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; 6 Department of Dermatology, Chi Mei Medical Center, Tainan, Taiwan; 7 Pharmaceutics Laboratory, Graduate Institute of Natural Products, Chang Gung University, Kweishan, Taoyuan, Taiwan; 8 Research Center for Food and Cosmetic Safety and Research Center for Chinese Herbal Medicine, Chang Gung University of Science and Technology, Kweishan, Taoyuan, Taiwan; 9 Department of Anesthesiology, Chang Gung Memorial Hospital, Kweishan, Taoyuan, Taiwan Correspondence: Ming-Hsien Lin, Department of Dermatology, Chi Mei Medical Center, 901 Zhonghua Road, Yongkang, Tainan, Taiwan, Email Jia-You Fang, Pharmaceutics Laboratory, Graduate Institute of Natural Products, Chang Gung University, 259 Wen-Hwa 1st Road, Kweishan, Taoyuan, 333, Taiwan, Email Psoriasis presents as a complex genetic skin disorder, characterized by the interaction between infiltrated immune cells and keratinocytes. Substantial progress has been made in understanding the molecular mechanisms of both coding and non-coding genes, which has positively impacted clinical treatment approaches. Despite extensive research into the genetic aspects of psoriasis pathogenesis, fully grasping its epigenetic component remains a challenging endeavor. In response to the pressing demand for innovative treatments to alleviate inflammatory skin disorders, various novel strategies are under consideration. These include gene therapy employing antisense nucleotides, silencing RNA complexes, stem cell therapy, and antibody-based therapy. There is a pressing requirement for a psoriasis-like animal model that replicates human psoriasis to facilitate early preclinical evaluations of these novel treatments. The authors conduct a comprehensive review of various gene therapy in different psoriasis-like animal models utilized in psoriasis research. The animals included in the list underwent skin treatments such as imiquimod application, as well as genetic and biologic injections, and the results of these interventions are detailed. Animal models play a crucial role in translating drug discoveries from the laboratory to clinical practice, and these models aid in improving the reproducibility and clinical applicability of preclinical data. Numerous animal models with characteristics similar to those of human psoriasis have proven to be useful in understanding the development of psoriasis. In this review, the article focuses on RNA-based gene therapy exploration in different types of psoriasis-like animal models to improve the treatment of psoriasis. Keywords: psoriasis, animal model, gene therapy, siRNA, miRNA Psoriasis vulgaris is the most common clinical manifestation of psoriasis, affecting approximately 90% of psoriasis patients. Psoriasis vulgaris is a long-lasting and noncommunicable condition to be characterized by pain, disfigurement, and disability. This disease impacts approximately 2% to 3% of the global population, manifesting as red, hardened, scaly patches on the skin, and can also affect the nails and joints. 1 This disease can occur in any sex at any age. 2 A recent study showed that instances of new-onset psoriasis or exacerbation of existing psoriasis were observed as cutaneous adverse events subsequent to COVID-19 vaccination. Therefore, psoriatic patients may necessitate frequent monitoring prior to and after receiving COVID-19 vaccination. 3 Depending on the type and severity of psoriasis, the treatment modalities can be employed either separately or in conjunction with one another. However, a major concern with the currently available therapies is that most of them are associated with side effects when administered orally or intravenously. 4 A diverse array of therapeutic approaches is commonly utilized in clinical practice for the management of psoriasis. A range of therapeutic techniques, including topical formulations such as gels and creams, phototherapy, systemic medications, and biologics, are utilized to manage moderate-to-severe psoriasis. 5 Given the changes in skin characteristics resulting from psoriasis and the adverse effects associated with systemic oral and biological treatments, exploration of innova -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal